Anuh Pharma LimitedNSE: ANUHPHR

ANUHPHR: FY26 revenue rose 15.66% to ₹776 Cr, driven by exports and regulatory market expansion

· Issued by Anuh Pharma Limited

FY26 saw 15.66% revenue growth to ₹776 Cr, with strong export performance and successful regulatory inspections. Investments in R&D, compliance, and capacity expansion support a robust product pipeline and long-term growth, with a 15-20% annual growth outlook.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Company analysis

Earlier from Anuh Pharma

All Anuh Pharma news releases